Omeros CorpNASDAQ:OMER
- LAST PRICE3.7900
- TODAY'S CHANGE (%)-0.1000 (-2.5707%)
- Bid / Lots3.7900/ 3
- Ask / Lots3.8000/ 14
- Open / Previous Close3.8600 / 3.8900
- Day Range
- 52 Week Range
- Volume231,526
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OMER |
|---|---|---|
| 09:32 ET | 1118 | 3.875 |
| 09:36 ET | 447 | 3.84 |
| 09:41 ET | 4762 | 3.8 |
| 09:45 ET | 500 | 3.8101 |
| 09:48 ET | 1000 | 3.815 |
| 09:50 ET | 1834 | 3.87 |
| 09:59 ET | 1200 | 3.86 |
| 10:01 ET | 12091 | 3.83 |
| 10:03 ET | 900 | 3.84 |
| 10:14 ET | 11815 | 3.83 |
| 10:17 ET | 1447 | 3.84 |
| 10:19 ET | 500 | 3.83 |
| 10:21 ET | 200 | 3.85 |
| 10:26 ET | 950 | 3.81 |
| 10:28 ET | 4787 | 3.795 |
| 10:32 ET | 396 | 3.783 |
| 10:33 ET | 1100 | 3.785 |
| 10:42 ET | 12337 | 3.7791 |
| 10:48 ET | 1104 | 3.78 |
| 10:50 ET | 886 | 3.81 |
| 10:53 ET | 100 | 3.815 |
| 10:55 ET | 210 | 3.8124 |
| 10:57 ET | 100 | 3.82 |
| 11:02 ET | 393 | 3.8 |
| 11:04 ET | 1526 | 3.815 |
| 11:13 ET | 200 | 3.83 |
| 11:20 ET | 1103 | 3.84 |
| 11:24 ET | 100 | 3.86 |
| 11:26 ET | 103 | 3.855 |
| 11:29 ET | 100 | 3.85 |
| 11:31 ET | 1816 | 3.84 |
| 11:33 ET | 1359 | 3.85 |
| 11:36 ET | 3147 | 3.86 |
| 11:38 ET | 501 | 3.8648 |
| 11:42 ET | 103 | 3.855 |
| 11:44 ET | 1235 | 3.87 |
| 11:49 ET | 103 | 3.875 |
| 11:51 ET | 306 | 3.875 |
| 11:54 ET | 654 | 3.88 |
| 11:56 ET | 1696 | 3.89 |
| 11:58 ET | 2445 | 3.87 |
| 12:16 ET | 1103 | 3.865 |
| 12:18 ET | 730 | 3.86 |
| 12:20 ET | 103 | 3.86 |
| 12:25 ET | 300 | 3.85 |
| 12:30 ET | 103 | 3.845 |
| 12:34 ET | 103 | 3.845 |
| 12:36 ET | 103 | 3.845 |
| 12:39 ET | 1200 | 3.83 |
| 12:45 ET | 383 | 3.82 |
| 12:52 ET | 392 | 3.82 |
| 12:59 ET | 300 | 3.82 |
| 01:01 ET | 1015 | 3.83 |
| 01:06 ET | 100 | 3.83 |
| 01:10 ET | 858 | 3.835 |
| 01:12 ET | 652 | 3.84 |
| 01:17 ET | 100 | 3.83 |
| 01:19 ET | 40694 | 3.7606 |
| 01:21 ET | 4200 | 3.765 |
| 01:24 ET | 600 | 3.76 |
| 01:26 ET | 500 | 3.76 |
| 01:28 ET | 3000 | 3.76 |
| 01:30 ET | 100 | 3.76 |
| 01:32 ET | 1100 | 3.765 |
| 01:35 ET | 393 | 3.765 |
| 01:44 ET | 371 | 3.764 |
| 01:48 ET | 1123 | 3.755 |
| 01:50 ET | 100 | 3.75 |
| 01:51 ET | 674 | 3.755 |
| 01:53 ET | 650 | 3.7537 |
| 01:55 ET | 100 | 3.75 |
| 01:57 ET | 6391 | 3.75 |
| 02:00 ET | 2417 | 3.76 |
| 02:06 ET | 100 | 3.765 |
| 02:15 ET | 1237 | 3.77 |
| 02:18 ET | 1200 | 3.78 |
| 02:24 ET | 382 | 3.79 |
| 02:26 ET | 972 | 3.79 |
| 02:38 ET | 302 | 3.77 |
| 02:40 ET | 717 | 3.7713 |
| 02:42 ET | 900 | 3.77 |
| 02:44 ET | 300 | 3.78 |
| 02:47 ET | 100 | 3.775 |
| 02:49 ET | 400 | 3.78 |
| 02:51 ET | 680 | 3.8003 |
| 03:00 ET | 1600 | 3.8 |
| 03:02 ET | 200 | 3.79 |
| 03:14 ET | 4861 | 3.77 |
| 03:16 ET | 170 | 3.78 |
| 03:18 ET | 100 | 3.77 |
| 03:21 ET | 258 | 3.765 |
| 03:23 ET | 300 | 3.765 |
| 03:36 ET | 3879 | 3.765 |
| 03:38 ET | 100 | 3.765 |
| 03:39 ET | 9119 | 3.7578 |
| 03:41 ET | 2015 | 3.77 |
| 03:43 ET | 11873 | 3.79 |
| 03:45 ET | 5612 | 3.79 |
| 03:48 ET | 1200 | 3.82 |
| 03:50 ET | 844 | 3.805 |
| 03:52 ET | 906 | 3.795 |
| 03:54 ET | 2195 | 3.79 |
| 03:56 ET | 949 | 3.79 |
Jun 4, 2024
Omeros Announces Webcast Details for Annual Meeting of Shareholders, from 9:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
9:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
DJ Omeros Shares Rise on Balance Sheet Strengthening, from 11:33AM ET on Monday Jun 03, 2024 by Dow Jones
11:33AM ET on Monday Jun 03, 2024 by Dow JonesOmeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028, from 9:00AM ET on Monday Jun 03, 2024 by Dow Jones
9:00AM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Omeros Corp | 225.4M | -1.3x | --- |
Tenaya Therapeutics Inc | 224.2M | -1.6x | --- |
ATAI Life Sciences NV | 226.0M | -5.4x | --- |
Solid Biosciences Inc | 222.6M | -1.4x | --- |
Gossamer Bio Inc | 228.5M | -0.9x | --- |
Skye Bioscience Inc | 221.2M | -1.7x | --- |
Company Information
Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders, including complement-mediated diseases, cancers, and addictive and compulsive disorders. Its lead MASP-2 inhibitor, narsoplimab, targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Its long-acting MASP-2 inhibitor, OMS1029, is in a phase I multi-ascending-dose clinical trial. OMS906, its inhibitor of MASP-3, the key activator of the alternative pathway of complement, is advancing in clinical programs for paroxysmal nocturnal hemoglobinuria and complement 3 glomerulopathy. The Company’s lead phosphodiesterase 7 inhibitor OMS527 is in clinical development for the treatment of cocaine use disorders.
Contact Information
- Headquarters
- 201 Elliott Avenue WestSEATTLE, WA, United States 98119
- Phone
- 206-676-5000
- Fax
- 206-676-5005
Executives
- Chairman of the Board, President, Chief Executive Officer
- Gregory Demopulos
- Chief Accounting Officer, Vice President - Finance
- Michael Jacobsen
- Vice President - Science, Chief Scientific Officer
- George Gaitanaris
- Vice President, General Counsel, Secretary
- Peter Cancelmo
- Vice President - Human Resources
- Peter Williams
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $225.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.45 |
EPS | $-2.90 |
Book Value | $-0.41 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
